Your browser is no longer supported. Please, upgrade your browser.
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E19.53 EPS (ttm)2.34 Insider Own0.20% Shs Outstand2.50B Perf Week1.44%
Market Cap113.00B Forward P/E14.13 EPS next Y3.23 Insider Trans0.00% Shs Float2.48B Perf Month6.01%
Income5.91B PEG4.76 EPS next Q0.63 Inst Own13.20% Short Float0.43% Perf Quarter16.65%
Sales45.67B P/S2.47 EPS this Y23.20% Inst Trans-0.02% Short Ratio2.56 Perf Half Y16.20%
Book/sh8.44 P/B5.41 EPS next Y6.35% ROA5.50% Target Price46.27 Perf Year20.17%
Cash/sh1.95 P/C23.46 EPS next 5Y4.10% ROE28.60% 52W Range33.53 - 46.85 Perf YTD3.61%
Dividend2.20 P/FCF29.31 EPS past 5Y-7.90% ROI17.30% 52W High-3.69% Beta0.73
Dividend %4.82% Quick Ratio0.50 Sales past 5Y7.30% Gross Margin67.90% 52W Low34.58% ATR0.63
Employees94066 Current Ratio0.80 Sales Q/Q5.00% Oper. Margin19.10% RSI (14)57.65 Volatility1.09% 1.10%
OptionableYes Debt/Eq1.66 EPS Q/Q-6.50% Profit Margin12.90% Rel Volume1.10 Prev Close45.69
ShortableYes LT Debt/Eq1.34 EarningsOct 27 BMO Payout16.10% Avg Volume4.20M Price45.12
Recom2.20 SMA201.64% SMA504.50% SMA20011.63% Volume3,211,792 Change-1.24%
Nov-05-21Upgrade Barclays Underweight → Equal Weight
Jun-24-21Upgrade Deutsche Bank Sell → Hold
Mar-23-21Downgrade SVB Leerink Outperform → Mkt Perform
Feb-04-21Downgrade Deutsche Bank Hold → Sell
Jan-20-21Downgrade Credit Suisse Neutral → Underperform
Jan-15-21Initiated Deutsche Bank Hold
Nov-02-20Upgrade Liberum Hold → Buy
Sep-29-20Initiated Berenberg Buy
Feb-12-20Downgrade Shore Capital Hold → Sell
Jan-16-20Downgrade Barclays Equal Weight → Underweight
Dec-02-19Initiated SVB Leerink Outperform
Nov-21-19Upgrade UBS Neutral → Buy
Oct-11-19Upgrade Cantor Fitzgerald Hold → Buy
Sep-03-19Upgrade Societe Generale Sell → Buy
Sep-03-19Resumed Citigroup Neutral
Aug-13-19Resumed JP Morgan Neutral
Jun-17-19Resumed Morgan Stanley Underweight
Mar-08-19Downgrade Shore Capital Buy → Hold
Feb-22-19Downgrade UBS Buy → Neutral
Jan-14-19Downgrade Exane BNP Paribas Outperform → Neutral
Jan-20-22 10:53AM  
10:09AM  
09:38AM  
09:13AM  
04:46AM  
04:30AM  
03:36AM  
03:02AM  
Jan-19-22 09:38PM  
03:23PM  
02:02PM  
12:52PM  
11:13AM  
06:57AM  
04:37AM  
03:29AM  
Jan-18-22 06:11PM  
05:23PM  
11:12AM  
09:38AM  
01:01AM  
Jan-17-22 01:52PM  
12:53PM  
12:49PM  
09:44AM  
08:42AM  
08:16AM  
06:28AM  
06:23AM  
06:04AM  
05:30AM  
04:55AM  
04:31AM  
04:09AM  
04:00AM  
02:45AM  
Jan-16-22 05:31PM  
02:31PM  
02:03PM  
Jan-15-22 01:30PM  
11:35AM  
11:01AM  
07:50AM  
06:05AM  
Jan-14-22 10:30AM  
10:07AM  
09:38AM  
Jan-13-22 06:01PM  
05:45PM  
10:35AM  
09:41AM  
09:02AM  
Jan-12-22 05:38PM  
12:54PM  
09:48AM  
Jan-11-22 05:50PM  
10:35AM  
10:03AM  
09:42AM  
09:02AM  
07:38AM  
07:12AM  
06:15AM  
Jan-10-22 03:07PM  
05:25AM  
Jan-07-22 04:26PM  
Jan-06-22 04:31PM  
03:18PM  
02:38PM  
02:20PM  
Jan-05-22 05:45PM  
04:22PM  
09:38AM  
Jan-04-22 05:50PM  
04:35PM  
08:48AM  
Jan-03-22 05:17PM  
04:52PM  
04:46PM  
10:46AM  
Dec-31-21 11:33AM  
Dec-30-21 06:33PM  
10:07AM  
Dec-29-21 04:56PM  
09:40AM  
Dec-28-21 05:08PM  
03:08PM  
Dec-27-21 04:58PM  
10:04AM  
Dec-24-21 09:13AM  
Dec-23-21 11:22AM  
Dec-22-21 11:11AM  
10:44AM  
10:27AM  
09:12AM  
Dec-21-21 06:00PM  
12:18PM  
11:24AM  
09:47AM  
07:12AM  
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GLAXOSMITHKLINE PLC10% OwnerJul 02Buy18.00275,0004,950,0001,007,583Jul 06 04:38 PM
GLAXOSMITHKLINE PLC10% OwnerMay 20Sale12.2532,005,260392,064,4350May 24 05:04 PM